Our Work

Clinical Research Training Program

CRTP Fellows 2011-2012

Clinical Research Training Program (CRTP) Fellows
2011-2012

Established in 1997, the Clinical Research Training Program (CRTP) is one of the Foundation for NIH’s premier public-private partnerships. With long-term support from Pfizer Inc, the program has enabled 340 of the country’s most promising medical and dental students to experience clinical research firsthand in an intensive, year-long, residential training program at the National Institutes of Health.

The goal of CRTP is to ensure that a talented, new generation of clinical investigators will work to fill the gap in clinical research—translating today’s discoveries into tomorrow’s therapies and cures. Each year, 30 fellows mentored by senior clinician-scientists participate in active research projects; attend clinical rounds, courses and seminars; and present their research findings to the NIH community.

To date, CRTP fellows have collectively published more than 240 articles based on their NIH research. Additionally, more than half have continued their research training; many have received public and/or private support for their research careers and 12 have returned to NIH to participate in additional clinical and research fellowships.

In the summer of 2012, the NIH will merge the Clinical Research Training Program (CRTP), currently in its 15th year, with the Howard Hughes Medical Institute (HHMI)-NIH Research Scholars Program, created 27 years ago.  Both programs, in their current formats, are ending this academic year (June 2012).

The new combined program—the Medical Research Scholars Program (MRSP)—is a comprehensive year-long research enrichment program for up to 70 medical, dental, and veterinary students.  The new MRSP will combine and build on the strengths of its highly successful predecessors, offering a broad range of exceptional research, career development, and innovation opportunities to the most promising of students.

The 2012-2013 Medical Research Scholars Program is co-sponsored by the NIH and the FNIH, via contributions from Pfizer Inc, the Leona M. and Harry B. Helmsley Charitable Trust, the Howard Hughes Medical Institute, and Alexandria Real Estate Equities, Inc.